Skip to main content
Premium Trial:

Request an Annual Quote

OGS Wins Patent, Files Another for BRCA Proteins

Premium

OXFORD, UK--Oxford Glyco-sciences's stock price climbed nearly 15 percent last week when it was awarded a US patent for high-throughput protein screening technology. The patent describes technologies for separating biological samples into 2-dimensional arrays, and then generating digitized images of the resulting patterns. Methods for quantitatively measuring proteins and protein changes exhibited between different biological samples are also provided in the patent.

Finally, the invention covers methods for automation and robotics to examine sample pattern differences, and to select specific proteins for sequence identification by methods such as mass spectrophotometry.

Oxford is using the technology in a joint venture with Incyte Genomics to create a proteomics database.

The company has also filed patent applications on proteins found within and on the surface membranes of breast cancer cells using its proprietary proteomic technologies and bioinformatics software. The company's chief scientific officer, Raj Parekh, claimed that the work represents the first time a "proteomics study of this breadth has been performed in any disease."

Filed under

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.